Explore how nanotechnology acts as the 'Convergence Engine' for AI materials discovery, CRISPR gene therapy delivery, and ...
Drs Harrington and Gibson’s annual review of cardiovascular medicine: ACS guidelines, antiplatelet management, GLP-1s, and ...
Trial data on epcoritamab plus rituximab-lenalidomide, a novel CELMoD agent, late-line CAR-T cell therapy, and selecting ...
Time really does fly. And when you look back at 2025, we’re sure you’ve collected a mix of moments: some joyful, some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback